CV Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -45.49%, SMA50 -22.94%, SMA200 7.47%). The stock’s 14-day RSI is 35.73 (weak momentum), while the ATR of 1.51 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -60.31% below its high and over 77.63% above its low. Average 10-day trading volume of 611.10 thousand shares is significantly above the 3-month average of 192.32 thousand, indicating heightened recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $14.00 to $5.00. The high target offers 129.51% upside. The low target suggests -18.03% downside. The mean target is $9.50. This offers 55.74% upside. CapsoVision, Inc. earnings surprise history is a mixed track record. The quarter that ended November 13, 2025, missed forecasts by 21.43%. The prior quarter beat by 1736.36%. Over the last six quarters, Apple has recorded several small beats. These include 1736.36% in August 14, 2025.

CapsoVision, Inc. has 46.77 million shares outstanding. This equals 1.99 thousand shares. The short ratio is 0.05 days. Institutional investors hold 0.09% of the float. Insiders own 40.69%.

Our AI price prediction model suggests that CapsoVision, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows CapsoVision, Inc. trading at a premium to the broader market with a P/E of -12.16. Analyst sentiment is cautious, with the majority of ratings in Speculative Buy territory and a mean price target of $9.50, suggesting 55.74% upside.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

CapsoVision, Inc. trades at a P/E ratio of -12.16, slightly below the S&P 500 average, with a price-to-sales ratio of 22.88 and a price-to-book ratio of 13.79 reflecting a rich premium to book value. The P/FCF stands at -15.02, also below market averages. Compared to sector medians, CapsoVision, Inc. P/S is trading rich, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

CapsoVision, Inc. (NASDAQ:CV) closed at $6.10 USD, losing -$0.90 (-12.86%) from the previous close of $7.00. The stock is currently mid-range between its 52-week high and low $3.43 and $15.37. With a market capitalization of about $285.53 million, CapsoVision, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 209.22 thousand shares, trading with heavier-than-usual volume. Headquartered in Saratoga, CA, CapsoVision, Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Kang Huai Wang, the company employs approximately 90 people and listed since September 03, 2001. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics